The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 78 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Helicobacter pylori  [Clear All Filters]
2023
Kountouras, J., Doulberis M., Papaefthymiou A., Polyzos S. A., Zavos C., Kazakos E., et al. (2023).  Controlling the Impact of -Related Hyperhomocysteinemia on Neurodegeneration.. Medicina (Kaunas). 59(3), 
Kountouras, J., Papaefthymiou A., Polyzos S. A., Kazakos E., Tzilves D., Touloumtzi M., et al. (2023).  Letter: higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbidities.. Aliment Pharmacol Ther. 57(10), 1186-1187.
2022
Kountouras, J., Doulberis M., Polyzos S. A., Kazakos E., Vardaka E., Tzitiridou-Chatzopoulou M., et al. (2022).  Emerging parameters relevant to the management of antimicrobial-resistant Helicobacter pylori infection.. Intern Med J. 52(9), 1654-1655.
Kountouras, J., Kazakos E., Polyzos S. A., Chatzopoulos D., Tzitiridou-Chatzopoulou M., Doulberis M., et al. (2022).  GM-CSF as a potential candidate of a vaccine-induced reduction of Helicobacter pylori infection.. Helicobacter. 27(3), e12884.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Kazakos E., Vardaka E., Touloumtzi M., et al. (2022).  Impact of Active Helicobacter pylori Infection-related Metabolic Syndrome on Systemic Arterial Hypertension.. Arq Bras Cardiol. 119(3), 502-504.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Liatsos C., Vardaka E., Touloumtzi M., et al. (2022).  Letter to the Editor Regarding "The Association of Helicobacter pylori, Eradication, and Early Complications of Laparoscopic Sleeve Gastrectomy" by Abeid et al.. Obes Surg. 32(6), 2079-2080.
Kountouras, J., Doulberis M., Polyzos S. A., Tzitiridou M., Chatzopoulos D., Gialamprinou D., et al. (2022).  A potential impact of Helicobacter pylori-related metabolic syndrome on early and long-term outcomes of bariatric surgery.. Gastrointest Endosc. 96(6), 1088-1089.
2020
Papaefthymiou, A., Doulberis M., Polyzos S. A., Katsinelos P., & Kountouras J. (2020).  Letter: Helicobacter pylori infection and its role in oesophageal adenocarcinoma.. Aliment Pharmacol Ther. 51(11), 1215-1216.
Boziki, M., Grigoriadis N., Doulberis M., Papaefthymiou A., Polyzos S. A., & Kountouras J. (2020).  Potential impact of Helicobacter pylori-related Galectin-3 on chronic kidney, cardiovascular and brain disorders in decompensated cirrhosis.. Dig Liver Dis. 52(1), 121-123.
2019
Mentis, A-F. A., Boziki M., Grigoriadis N., & Papavassiliou A. G. (2019).  Helicobacter pylori infection and gastric cancer biology: tempering a double-edged sword.. Cell Mol Life Sci. 76(13), 2477-2486.
Doulberis, M., Papaefthymiou A., Polyzos S. A., Boziki M., Deretzi G., Giartza-Taxidou E., et al. (2019).  Microbes and Alzheimer' disease: lessons from H. pylori and GUT microbiota.. Eur Rev Med Pharmacol Sci. 23(5), 1845-1846.
2018
Kountouras, J., Doulberis M., Polyzos S. A., Zeglinas C., Vardaka E., Kountouras C., et al. (2018).  Helicobacter pylori Infection and Gastroesophageal Reflux Disease-Barrett's Esophagus-Esophageal Adenocarcinoma Sequence.. Am J Gastroenterol. 113(11), 1723-1724.
Kountouras, J., Polyzos S. A., Katsinelos P., Anastasiadis S., Tzivras D., Doulberis M., et al. (2018).  Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology.. Dig Dis Sci. 63(4), 1087-1088.
Kountouras, J., Polyzos S. A., Doulberis M., Zeglinas C., Artemaki F., Vardaka E., et al. (2018).  Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis.. Metabolism. 87, 18-24.
2017
Kountouras, J., Kapetanakis N., Polyzos S. A., Katsinelos P., Gavalas E., Tzivras D., et al. (2017).  Active Infection Is a Risk Factor for Colorectal Mucosa: Early and Advanced Colonic Neoplasm Sequence.. Gut Liver. 11(5), 733-734.
Kountouras, J., Polyzos S. A., Katsinelos P., Zeglinas C., Artemaki F., Tzivras D., et al. (2017).  Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy.. Int J Cardiol. 229, 17-18.
Kazakos, E. I., Dorrell N., Polyzos S. A., Deretzi G., & Kountouras J. (2017).  Comment on "Effect of biofilm formation by clinical isolates of Helicobacter pylori on the efflux-mediated resistance to commonly used antibiotics".. World J Gastroenterol. 23(33), 6194-6196.
Kountouras, J., Polyzos S. A., Katsinelos P., Zeglinas C., Artemaki F., Tzivras D., et al. (2017).  Helicobacter pylori eradication to prevent cardio-cerebrovascular disease: Are current data useful for clinical practice?. Int J Cardiol. 233, 92.
Kountouras, J., Polyzos S. A., Katsinelos P., Tzivras D., Boziki M., Gavalas E., et al. (2017).  Helicobacter pylori on portal hypertension-related hepatic encephalopathy.. Immunopharmacol Immunotoxicol. 39(2), 105-106.
Kountouras, J., Polyzos S. A., Zeglinas C., & Katsinelos P. (2017).  Helicobacter pylori-related chronic hepatitis C infection and the risk for cardiovascular disease.. Liver Int. 37(7), 1082.
Kountouras, J., Polyzos S. A., Zeglinas C., Tzathas C., Nikolaidis N., Vardaka E., et al. (2017).  Helicobacter pylori-related metabolic syndrome as predictor of progression to esophageal carcinoma in a subpopulation-based Barrett's esophagus cohort.. Gastrointest Endosc. 85(2), 462-463.
Kountouras, J., Boziki M., Polyzos S. A., Katsinelos P., Gavalas E., Zeglinas C., et al. (2017).  Impact of reactive oxygen species generation on Helicobacter pylori-related extragastric diseases: a hypothesis.. Free Radic Res. 51(1), 73-79.
Kountouras, J., Polyzos S. A., Katsinelos P., Doulberis M., Zavos C., Kazakos E., et al. (2017).  Letter: Helicobacter pylori in lean and obese patients with non-alcoholic fatty liver disease.. Aliment Pharmacol Ther. 46(6), 637-638.
Kountouras, J., Polyzos S. A., Kapetanakis N., Katsinelos P., Nikolopoulos P., Stogianni A., et al. (2017).  Letter: Helicobacter pylori-related non-alcoholic fatty liver disease with concomitant metabolic syndrome as risk factor for colorectal neoplasia.. Aliment Pharmacol Ther. 45(4), 576-577.
Kazakos, E. I., Kountouras J., Polyzos S. A., & Deretzi G. (2017).  Novel aspects of defensins' involvement in virus-induced autoimmunity in the central nervous system.. Med Hypotheses. 102, 33-36.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.